The first-of-its-kind, GLO Science Teeth Whitening delivers professional quality, sensitivity-free gel formulation in a one-step, patented G-Vial brush tip applicator capsule. Featuring individual, hermetically sealed vials making it possible to whiten on-the-go. This unique addition to Solazyme's Algenist skincare line is the first product to feature sustainable, microalgae-derived oil and has been proven to significantly improve cell repair and regeneration, outperforming other anti-aging products.
Cecil and Ida Green Distinguished Professor of Biological and Mechanical Engineering, Massachusetts Institute of Technology MIT Overview Select Biosciences Point-of-Care Diagnostics Europe brings together the key opinion leaders from both academia and industry, this annual conference will discuss the expanding Point-of-Care Diagnostics and Global Health fields and provide the most up-to-date presentations from leaders in these fields and offer networking and engagement opportunities with delegates from around the world.
This conference will provide an overview of the point-of-care POC testing landscape, from novel technologies to regulatory approval.
Experts in these fields will share their views on point-of-care in the clinical setting. The aim of this meeting is to bring together life science researchers that work at the interface between biology and chemistry and technology development to discuss problems, highlight solutions and facilitating collaborations.
Also, we frame the role of POC testing in the expanding Global Health field and highlight opportunities existing in many parts of the world.
We address each of these segments in this conference. Registered conference delegates have access to the co-located parallel conference tracks: Information and Local Registration Facilities for this conference are also available in:prenatal molecular diagnostics conference Cell-free DNA-based screening and the potential for cell-based screening has upended the field of prenatal testing.
While cell-free tests are being used more and more in the clinic, cell-based tests are still on the cusp of commercialization. With both types of tests still in need of improvements in order to truly replace invasive tests, the near-term. DxNow’s products are based on exclusively licensed worldwide patent rights to platform technologies developed by Dr.
Demirci and his team at the Demirci Bio-Acoustic MEMS in Medicine Labs (BAMM) at Brigham & Women’s Hospital and Stanford Medicine. Tissue diagnostics Point-of-care diagnostics Women’s health Critical care Roche Diagnostics offers the industry’s broadest range of dia-gnostic tests.
Our pioneering technologies and solutions not only Millions of people worldwide are now tak-.
Alere - Abbott merger has changed market share in Point of Care Diagnostics. Substance abuse testing is the largest segment of professionally-administered POC testing.
BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The Worldwide Market for In Vitro Diagnostic Tests is a testament to the Kalorama methodology.
It is the result of months of painstaking work by an experienced IVD industry analyst, who has tracked hundreds of in vitro diagnostic companies for developments, trends and financial results.